[The Sixth Batch of Key Enterprises Introduced to Hong Kong Announced, Including Cobo and RedotPay] According to a report by Golden Finance, the Office for Attracting Strategic Enterprises (OASES) in Hong Kong announced the sixth batch of key enterprises on the 20th. The list includes major U.S. pharmaceutical company Pfizer, leading mainland pharmaceutical company Hengrui Medicine, chip design firm Haiguang Information, digital asset custody institution Cobo Fintech HK Limited, and stablecoin payment fintech company RedotPay, among others. During the signing ceremony, Paul Chan stated that the enterprises have diverse backgrounds. Currently, there are 124 key enterprises, which are expected to bring HK$73 billion in investments and create 25,000 new jobs. He mentioned that 75% of these companies plan to establish regional or international headquarters in Hong Kong, 90% will set up research centers, and many are interested in settling in the Northern Metropolis.